Review; post‐marketing surveillance of the safety of cimetidine—the problems of data interpretation

Publisher Website
Google Scholar
Abstract
SUMMARY: Experience obtained during post‐marketing surveillance of the safety of cimetidine emphasizes the difficulties in interpretation posed by the high background frequency of disease of all types in drug takers. The multiple sources of confounding factors, and their high prevalence, make it impossible to detect adverse events which mimic ordinary disease, particularly when a consistent relationship between adverse event and drug exposure is not observed. The inclusion of controls emphasizes the difficulties but does not ease interpretation.